StreetInsider
Log in to your account:
Log in
Signup
Home
EPS Insider
Event Calendar
Conferences
Classic Site
Upgrade to SI Premium - Free Trial
Jefferies Reiterates Buy Rating on BioNTech (BNTX)
March 10, 2025 2:23 PM
Jefferies analyst Akash Tewari reiterated a Buy rating and $149.00 price target on BioNTech (NASDAQ: BNTX).The analyst comments "Bottom line ...
(Premium-only article. Please sign in or upgrade to SI Premium to view.)
Categories
Analyst Comments
Next Articles
BioNTech (BNTX) PT Lowered to $151 at Truist Securities
March 11, 2025 11:46 AM
BioNTech (BNTX) PT Lowered to $143 at BofA Securities
March 10, 2025 12:44 PM
BioNTech SE (BNTX) Reports Q4 EPS of EUR1.08; offers guidance
March 10, 2025 7:24 AM
Form 20-F BioNTech SE For: Dec 31
March 10, 2025 7:01 AM
Form 6-K BioNTech SE For: Mar 10
March 10, 2025 6:58 AM
CDC Plans Large Study Into Potential Connections Between Vaccines and Autism - Reuters
March 7, 2025 11:12 AM
BioNTech SE (BNTX) call put ratio 1 calls to 3.6 puts with a focus on March puts
March 7, 2025 11:04 AM
